Age-Related Macular Degeneration
Showing 26 - 50 of >10,000
Neovascular (Wet) Age-related Macular Degeneration (nAMD) Trial (EXG102-031)
Not yet recruiting
- Neovascular (Wet) Age-related Macular Degeneration (nAMD)
- EXG102-031
- (no location specified)
Jun 13, 2023
OKKO Health Hyperacuity, Contrast and Colour Game Validation in
Recruiting
- Age-Related Macular Degeneration
-
Bristol, United KingdomBristol
Nov 16, 2022
Age Related Macular Degeneration (AMD) Trial in Decatur (SPIN, Non-aerobic, stretching/balance intervention Control)
Not yet recruiting
- Age Related Macular Degeneration (AMD)
- SPIN
- Non-aerobic, stretching/balance intervention Control
-
Decatur, GeorgiaAtlanta VA Medical and Rehab Center, Decatur, GA
Jun 26, 2023
Early Real-world Evidence of Brolucizumab in Neovascular
Completed
- Neurovascular Age-related Macular Degeneration
-
Bangalore, India
- +3 more
Apr 26, 2023
Neovascular Age-related Macular Degeneration Trial in Beijing (IBI333)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- IBI333
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Nov 28, 2022
Age-Related Macular Degeneration, Retinitis Pigmentosa, Ultrasound Therapy; Complications Trial (Non-invasive ultrasound retinal
Not yet recruiting
- Age-Related Macular Degeneration
- +2 more
- Non-invasive ultrasound retinal stimulation Device
- (no location specified)
Jun 19, 2023
Non-invasive Optical Angiography in Age-related Macular
Recruiting
- Age Related Macular Degeneration
- Non-invasive OCT based optical angiography
- +3 more
-
Vienna, AustriaMedical University of Vienna
Jan 13, 2023
Age-Related Macular Degeneration, Geographic Atrophy Trial in Holon (smaller incision, new generation implantable miniature
Not yet recruiting
- Age-Related Macular Degeneration
- Geographic Atrophy
- smaller incision, new generation implantable miniature telescope (SING-IMT)
-
Holon, Tel Aviv, IsraelWolfson Medical Center
Jul 3, 2023
Data of Intravitreal Aflibercept Injection in Patients of Wet
Completed
- Wet Age-related Macular Degeneration
- Aflibercept (Eylea, BAY86-5321)
-
Multiple Locations, IndiaMany Locations
Feb 2, 2023
Age-Related Macular Degeneration, Nonexudative Age-related Macular Degeneration Trial (Active microcurrent therapy)
Completed
- Age-Related Macular Degeneration
- Nonexudative Age-related Macular Degeneration
- Active microcurrent therapy
- (no location specified)
Jan 28, 2023
Age-Related Macular Degeneration Trial run by the NEI (iPSC-derived RPE/PGLA transplantation)
Recruiting
- Age-Related Macular Degeneration
- iPSC-derived RPE/PLGA transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Geographic Atrophy Trial (BI 771716)
Not yet recruiting
- Geographic Atrophy
- BI 771716
- (no location specified)
Aug 29, 2023
Age-Related Macular Degeneration, Dry Age-related Macular Degeneration, Nonexudative Age-related Macular Degeneration Trial in
Recruiting
- Age-Related Macular Degeneration
- +2 more
- i-Lumen(TM) AMD
- i-Lumen(TM) AMD Sham
-
Phoenix, Arizona
- +2 more
Sep 1, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),
Suspended
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- Intravitreal injection of IBI302(dose 1)
- +3 more
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jul 17, 2023
Therapy of Age-related Macular Degeneration
Recruiting
- Age-Related Macular Degeneration
-
Ried Im Innkreis, Upperaustria, AustriaBHS Ried
Aug 16, 2022
Age-Related Macular Degeneration Trial in Beijing (KH631)
Not yet recruiting
- Age-Related Macular Degeneration
-
Beijing, ChinaBeijing Tongren Hospital, Capital Medical University
Jan 3, 2023
Age-related Macular Degeneration, Geographic Atrophy Trial (VOY-101)
Recruiting
- Age-related Macular Degeneration
- Geographic Atrophy
- VOY-101
-
Bellaire, TexasRetina Consultants of Texas
Nov 17, 2022
Wet Age-related Macular Degeneration Trial in Beijing (RC28-E, Aflibercept)
Recruiting
- Wet Age-related Macular Degeneration
-
Beijing, Beijing, ChinaBeijing Hospital
Feb 3, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Austin (AIV007)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
-
Austin, TexasRetina Consultants of Austin
Jan 16, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Mesa, Phoenix (Faricimab PFS Configuration)
Completed
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- Faricimab PFS Configuration
-
Mesa, Arizona
- +2 more
Jan 2, 2023
Russian Registry of Patients With nAMD
Terminated
- Neovascular Age-Related Macular Degeneration
- nAMD
- (no location specified)
Jan 16, 2023
VeriSee AMD in Screening for Age-Related Macular Degeneration
Completed
- Macular Degeneration, Age Related
- Maculopathy, Age Related
-
Taipei, TaiwanNational Taiwan University Hospital
Oct 23, 2022
Age-related Macular Degeneration Trial in Israel, United States (OpRegen)
Completed
- Age-Related Macular Degeneration
- OpRegen
- (no location specified)
Nov 1, 2022
Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME) Trial in United States (EYE103)
Recruiting
- Neovascular Age-related Macular Degeneration (NVAMD)
- Diabetic Macular Edema (DME)
-
Phoenix, Arizona
- +4 more
Jun 14, 2023
Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in Tehran (Aflibercept (CinnaGen Co, Iran),
Completed
- Age-Related Macular Degeneration
- Neovascular Age-related Macular Degeneration
- Aflibercept (CinnaGen Co, Iran)
- Aflibercept (Regeneron, USA)
-
Tehran, Iran, Islamic Republic ofFarabi Hospital
Oct 16, 2022